This Startup Just Raised $6 Million For An App That Helps Treat Addiction
Summary
Affect TherapeuticsAffect Therapeutics, a company working to treat stimulant use disorder through mobile technology, announced Tuesday that it has raised $6 million in a seed investment round. As he saw a lack of standard of care and FDA approved medication assisted therapy, De Flavio constructed a team of advisors and was introduced to his fellow cofounder and CEO of Affect Therapeutics, Kristin Muhlner. “In using these different types of incentive structures we can create a compulsion loop and keep the process interesting and engaging for the patient.” With the new influx of capital, the company is looking to operate in Arizona, Kentucky and Nevada with the goal to be active in 20 states by the end of next year as well as further develop the data analytics to push the technology platform forward. Because : In times of chaos, your investment is your anchor to success Some GOP politicians needlessly make ivermectin problem worse.MaddowBlog: Too many Americans are turning to livestock deworming medication to treat Covid-19. Bidens child allowance helped feed 2 million kids in its first monthBusiness Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.